Study to Evaluate the Effect of ALS-008176 on Cardiac Repolarization Interval in Healthy Participants
Clinical trial NCT02833831 · COMPLETED
Trial details
- NCT number
- NCT02833831
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-02
- Primary completion
- 2017-02-17
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.